Research & IP · United States

Beam Therapeutics

Leader in base editing, a precision gene-editing technology that changes single DNA letters without double-strand breaks.

Headquarters
Cambridge, Massachusetts, United States · North America
Value chain
Research & IP(Research & design)
What that means
Invents and licenses: corporate and contract research, IP and technology licensing, with little production of its own.
Founded
2017
Ownership
Listed
Listing
Nasdaq:BEAM on Google Finance
Website
beamtx.com
Relevance
High at its strongest, in Synthetic Biology & Genetic Engineering

In 1 capability

Each capability the company is listed in, most relevant first: how experts in the field see its global relevance there, why it is listed and the source.

  1. Biotechnology & Health Technologies · Research · listed #12 of 50

    Leader in base editing, a precision gene-editing technology that changes single DNA letters without double-strand breaks.

    Relevance: Leader in base editing technology

    Source · en.wikipedia.org